Amy Mathers, MD, Associate Professor of Medicine & Pathology, Division of Infectious Disease and International Health at UVA has been studying molecular epidemiology for more than ten years. Her expertise in tracking bacterial DNA sequences has a...
In September 2016, Samsung issued a massive recall of the Galaxy Note 7 phone after a manufacturing defect caused the phones’ batteries to generate excessive heat and catch fire. The exploding phone PR nightmare gave everyone who carries a cell phone...
In 2008, UVA Professor of Infectious Disease, Paul Hoffman, Ph.D. along with one of UVA’s most prolific inventors and two-time winner of the Innovator of the Year Award (1997, 2010), Professor of Chemistry and Pharmacology Tim Macdonald, Ph.D. submit...
UVA Biology Professor, Michael Timko, Ph.D. has been studying functional genomics of plants at UVA for over 30 years. He has conducted sponsored research ranging from the examination of photosynthetic efficiency of pine trees in the southern United S...
The Fund’s fourth investment aims to drive FDA approval process of novel medical device May 16, 2018 (Charlottesville, VA) – The University of Virginia Licensing & Ventures Group (LVG) Seed Fund announced today its fourth investment - 510 Kardiac...
While UVA Engineering Professor Jim Smith refines the MadiDrop+ technology in the lab, LVG works to launch the new venture Silivhere Technologies that will bring this water purification product to those who need it most. Civil and environmental engi...
In the heart of every UVA research lab are the students working alongside faculty to advance ideas. Jason Papin, Professor of Biomedical Engineering at UVA runs the Computational Systems Biology Lab where undergraduate, graduate, and post-doctoral fe...
April 18, 2018 By: Christine Phelan Kueter UVA Nursing: https://www.nursing.virginia.e... After long shifts working in the Neonatal Intensive Care Unit (NICU) at UVA, Tricia Cady (RN to BSN `18) used to lie in bed in the dark and ruminate about ways ...
UVA Today By: Fariss Samarrai In August, the U.S. Food and Drug Administration approved the latest iteration of the burgeoning field of immune therapy for cancer, in this case allowing the genetic modification of a patient’s own immune cells so that ...
September 12, 2017 UVA Today By: Katie McNally, [email protected] In the early 1990s, Dr. Robert M. Berne designated a portion of the royalties from a drug that he helped commercialize to support cardiovascular research at the University of ...